2
N. Vasylieva et al. / Environment International xxx (2017) xxx–xxx
low fipronil doses (up to 3 mg/kg bw/day) did not experience abnormal
weight gain or severe neurological effects (usually 6–30 mg/kg bw for
flea and tick control). However, other signs of toxicity were observed in-
cluding convulsions, head nodding and muscles twitching (Hamernik,
1998; Woodward, 2012). Herin et al. (2011) assessed serum concentra-
tions of thyroid-stimulating hormone (TSH), fipronil and fipronil sul-
fone in 159 workers in a factory manufacturing fipronil-containing
veterinary drugs. They found a significant positive correlation between
exposure and fipronil/fipronil sulfone concentration in the blood. In ad-
dition, fipronil sulfone concentration correlated negatively with serum
TSH. Authors suggested the possibility that fipronil has a central inhibi-
tory effect on TSH secretion in humans that potentially leads to adverse
health consequences, the major one being loss of bone density and oste-
oporosis (Clark et al., 2010; Ozkaya et al., 2015). Thereby they empha-
sized that close occupational medical surveillance is highly desired to
monitor the exposure of factory workers to fipronil in order to maintain
health and well-being.
A number of studies were conducted to determine fipronil distribu-
tion and metabolism in mammals, as well as to identify its metabolites
as potential biomarkers of exposure to fipronil (Cravedi et al., 2013;
FAO, 2001; McMahen et al., 2015). Fipronil sulfone is a commonly ac-
cepted and proven major metabolite in all tissues, excrement, and
blood (Cravedi et al., 2013; FAO, 2001; McMahen et al., 2015). Patients
with signs of distress indicating potential poisoning with fipronil are
usually subjected to blood analysis to identify the parent compound or
fipronil sulfone (Mohamed et al., 2004). However, blood screening is
an invasive method causing discomfort, pain and carries a risk of devel-
2.2. Enzymatic hydrolysis of urine
Urine aliquots of 250 μL were mixed with 150 μL of methanol and
hydrolyzed using a 100 μL solution containing 33 μL (85,000/
7500 U/mL) of β-glucuronidase/sulfatase and 1.1 mL of 1 M ammonium
acetate buffer at pH 5.5. The reaction was left overnight at 37 °C with
gentle mixing.
2.3. Hydroxy-fipronil identification
Analysis was carried out with a method reported by McMahen et al.
(2015). Briefly, an Agilent 1100 HPLC interfaced with an Agilent 6210
(TOF) mass spectrometer fitted with an electrospray ionization (ESI)
source was used. The HPLC was performed with a Zorbax Eclipse Plus
C18 column (2.1 × 50 mm, 3.5 μm, Agilent Technologies) fitted with a
Phenomenex guard column (Torrance, CA). The method consisted of
the following: 0.2 mL/min flow rate; at 30 °C; mobile phases: A: ammo-
nium formate buffer (0.4 mM) and DI water:methanol (95:5 v/v), and
B: ammonium formate (0.4 mM) and methanol:DI water (95:5 v/v);
gradient: 0–5 min a linear gradient from 50:50 A:B to 100% B; 5–
15 min, 100% B; 15–18 min re-equilibration to 50% A and 50% B.
2.4. Method 1 (the Hammock group). For fipronil sulfone and hydroxy-
fipronil
Rat urine samples (40 μL) were mixed with 10 μL of 1 μM 12-(3-
cyclohexyl-ureido)-dodecanoic acid (CUDA) methanol solution. We
used CUDA as an external standard since it showed a retention time
close to fipronil sulfone, as well as spike-recovery studies with blank
urine matrix showed CUDA to be an appropriate standard to account
for ion suppression. The samples were cleared with a centrifugal filter
device under 20,000g for 5 min. The resulting solutions were transferred
to vials with 100 μL volume inserts, and stored at −20 °C prior to anal-
ysis. Separation of the target compounds was performed on an UPLC
system (Waters Corp., Milford, MA). Samples were stored in an
autosampler at 4 °C, and 10 μL were injected by a partial loop with nee-
dle overfill. The UPLC column Kinetex C18 (1.7 μm, 2.1 × 100 mm, 1.7
μm particle size, Kinetex, Phenomenex) was kept at 40 °C. Mobile
phases were composed of water with 0.1% acetic acid (phase A) and ace-
tonitrile with 0.1% acetic acid (phase B). The following gradient was ap-
plied: 0–3 min 20% B, 3.1–6 min, a linear gradient from 20 to 80% B, 6.1–
8 min, a linear gradient from 80 to 100% B, 8.1–9.1 min, 100% B, 9.1–
10 min re-equilibration to 20%. The flow rate remained constant at
0.4 mL/min. The run event was designed to pre-purify samples online,
0–3 min to waste; 3–8 min to MS; 8–10 min to waste. The UPLC system
was interfaced with the Quattro Premier MS equipped with an ESI
source operated in positive ionization mode. MS operating parameters
and compound specific information are provided in the SI, Tables S1
and S2. The data were acquired and processed using Masslynx 4.1 soft-
ware with instrument and Masslynx 4.1 with TargetLynx.
oping infection. Therefore, urine is
a much more convenient
biospecimen for screening tests. Two recent studies performed a de-
tailed analysis of urine samples obtained from rats treated with a
fipronil-containing diet (Cravedi et al., 2013; McMahen et al., 2015).
Based on mass fragmentation of the compound both teams assigned a
structure of hydroxy-fipronil but it has not been proven by analytical
methods. Nevertheless, based on signal ratios in chromatograms
McMahen et al. (2015) provided an estimate of concentration of metab-
olites present in the urine. From these data, hydroxy-fipronil appears to
be a dominant metabolite among the other identified metabolites of
fipronil.
The specific objectives of this study were to develop an approach for
the synthesis of hydroxy-fipronil and use it as a standard to verify the
identity of the discovered metabolite. A synthetic standard of hy-
droxy-fipronil was tested on mammalian GABAA receptors to character-
ize the biological activity of the new compound. It was also used to
assess its toxicity to insects. Finally, hydroxy-fipronil was used to devel-
op a high performance liquid chromatography method (HPLC) coupled
with tandem mass spectrometry detection (MS/MS) to provide a quan-
titative estimate of the biomarker in the urine of treated animals.
2. Materials and methods
Information concerning chemicals, instruments, buffers, reagents
and synthesis is detailed in the Supporting Information (SI) or in the
sections below.
2.5. LC/MS/MS analysis. Method 2 (the EPA group). For fipronil sulfone only
Method 2 is an alternative method for fipronil sulfone quantification
and for independent evaluation of the accuracy of method 1. Analysis
was carried out with a method reported by McMahen et al. (2015).
Briefly, rat urine (100 μL) was precipitated with 900 μL of cold acetoni-
trile and centrifuged for 8 min at 12,500 ×g. An aliquot of the superna-
tant was extracted and mixed 50:50 with 10 mM ammonium acetate
buffer before LC/MS analysis. Quantification analysis (LC/triple-quad)
was carried out using an Agilent 1100 HPLC interfaced with a Sciex
3000 triple quadrupole mass spectrometer (Applied Biosystems/MDS
Sciex) fitted with an ESI operated in the negative ionization mode.
Fipronil sulfone specific transitions used for quantification were 451.1/
415, 451.1/281.9, 451.1/243.9. The HPLC system consisted of a
Phenomenex Luna C18 column (50 × 3 mm, 5 μm; Torrance, CA, USA)
2.1. Urine samples
Urine samples were generated as part of a study reported by
Freeborn et al. (2015). Briefly, rats were treated by oral gavage with a
fipronil-containing corn oil using an 18 Ga feeding needle with a blunt
tip. Animals were treated daily at 5 or 10 mg/kg either for two weeks
(repeated) or on a single day only. Urine was collected in a syringe ei-
ther from voids on a clean table or via bladder puncture and transferred
to a micro-centrifuge tube, immediately frozen on dry ice, and stored at
−80 °C.
Please cite this article as: Vasylieva, N., et al., Hydroxy-fipronil is a new urinary biomarker of exposure to fipronil, Environ Int (2017), http://